Shayeste Bazsefidpar
Artificial Intelligence and Computational Chemistry: A New Era in Drug Design
Shayeste Bazsefidpar, Computational Chemist and Research Collaborator at the University Hospital of Santiago de Compostela, explores how artificial intelligence is transforming modern drug discovery. By combining AI with molecular modeling, scientists can now simulate complex biomolecular interactions, predict protein structures, and design new biological drugs faster and more efficiently.
Carmen Alarcón
From data to the clinic: The role of bioinformatics in precision medicine
Carmen Alarcón, a specialist in Molecular Biology and Bioinformatics, explains how the integration of omic, clinical, and medical imaging data is transforming the diagnosis and treatment of diseases. As part of the Computational Hematology and Genomics Group, she works on developing a platform that combines bioinformatic analysis and artificial intelligence to provide a comprehensive and personalized view of each patient.
Davide Crucitti
Artificial intelligence to discover the drugs of the future
Davide Cruciti, a computational chemist at the University Clinical Hospital of Santiago de Compostela, is researching how to apply artificial intelligence to the design of new treatments for acute myeloid leukaemia. His work seeks to accelerate and streamline the drug development process, reducing years of research and paving the way for faster, more accurate medicine capable of tackling multiple diseases at the same time.
Translated with DeepL.com (free version)